Scepticism in press over Kintor’s COVID-19 US drug trial
pharmaphorum
MAY 14, 2021
But Reuters reported that the doctor identified as its principal clinical trial investigator has said he is not in charge of the trial. Reuters quoted Kintor’s chief financial officer Lucy Lu, who said that Kayali was one of its trial investigators.
Let's personalize your content